Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloidal Bismuth Sub-citrate as Adjunctive Therapy for Helicobacter Pylori Elimination in Children
NCT03299725Phase 4Unknown
- Sponsor
- Queen Fabiola Children's University Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by Queen Fabiola Children's University Hospital. Status: unknown.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03299725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299725.